This is the authors' abstract. We don't add key points for this paper.
T-cell malignancies represent a broad, highly heterogeneous grouping of clinicobiological entities, some of which are defined by exclusion. Although T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) derives from T-cell precursors (eg, thymocytes), other entities such as T-cell large granular
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sehn et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: